Molly Min He

USPTO Granted Patents = 59 (Patent Applications = 38)

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 17 (Patent Applications = 27)

Average Co-Inventor Count = 5.6

ph-index = 17

Forward Citations = 1,105(Granted Patents)

Forward Citations (Not Self Cited) = 935(Dec 10, 2025)

Location History:

Palo Alto, CA (US) (2012 - 2013)
San Francisco, CA (US) (2018 - 2020)
San Diego, CA (US) (2016 - 2024)

Company Filing History:

Element Biosciences, Inc.

patents

5 out of 432

Pacific Biosciences of California, Inc.

patents

4. 2 out of 31

Illumina Singapore Pte. Ltd.

patents

5. 1 out of 305

Illumina Cambridge Limited

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Nucleic Acid Synthesis

CRISPR-Cas Systems

Polymerase-Nucleotide Conjugates

Multivalent Binding Composition

Transposase Compositions

Reverse Transcriptase

Single Molecule Sequencing

Kinetic Analysis

Therapeutic Agent Discovery

Nucleic Acid Analysis

Modified Polymerases

Pairwise Sequencing

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12416048 - Nucleic acid synthesis techniques (2025-09-16),

2. 12391983 - Polynucleotide enrichment and amplification using CRISPR-Cas or Argonaute systems (2025-08-19),

3. 12391929 - Polymerase-nucleotide conjugates for sequencing by trapping (2025-08-19),

4. 12331356 - Multipart reagents having increased avidity for polymerase binding (2025-06-17),

5. 12313627 - Multivalent binding composition for nucleic acid analysis (2025-05-27),

6. 12297498 - Conformational probes and methods for sequencing nucleic acids (2025-05-13),

7. 12241891 - Multivalent binding composition for nucleic acid analysis (2025-03-04),

8. 12180468 - Transposase compositions for reduction of insertion bias (2024-12-31),

9. 12117438 - Multivalent binding composition for nucleic acid analysis (2024-10-15),

10. 12110514 - Modified polymerases for improved incorporation of nucleotide analogues (2024-10-08),

11. 12091657 - Reverse transcriptase for nucleic acid sequencing (2024-09-17),

12. 11891651 - Compositions and methods for pairwise sequencing (2024-02-06),

13. 11873480 - Contiguity preserving transposition (2024-01-16),

14. 11859241 - Compositions and methods for pairwise sequencing (2024-01-02),

15. 11795581 - Platform for discovery and analysis of therapeutic agents (2023-10-24),

Title: The Innovative Journey of Molly Min He

Introduction: Molly Min He is a pioneering inventor based in San Diego, CA, known for her groundbreaking contributions to various fields.

Latest Patents: Molly Min He holds several patents in the areas of biotechnology, renewable energy, and medical devices, showcasing her diverse range of expertise.

Career Highlights: With a background in bioengineering, Molly Min He has led research teams in developing cutting-edge technologies that have the potential to revolutionize the industry.

Collaborations: Throughout her career, Molly Min He has collaborated with leading universities, research institutions, and companies to bring her inventions to life, fostering a culture of innovation and collaboration.

Conclusion: Molly Min He's relentless pursuit of innovation and her passion for creating solutions to complex challenges make her a true trailblazer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.